Cidfusituzumab

Jump to: navigation, search
Cidfusituzumab
Monoclonal antibody
Type?
SourceTemplate:Infobox drug/mab source
TargetIL-2
Identifiers
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Cidfusituzumab

Articles

Most recent articles on Cidfusituzumab

Most cited articles on Cidfusituzumab

Review articles on Cidfusituzumab

Articles on Cidfusituzumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cidfusituzumab

Images of Cidfusituzumab

Photos of Cidfusituzumab

Podcasts & MP3s on Cidfusituzumab

Videos on Cidfusituzumab

Evidence Based Medicine

Cochrane Collaboration on Cidfusituzumab

Bandolier on Cidfusituzumab

TRIP on Cidfusituzumab

Clinical Trials

Ongoing Trials on Cidfusituzumab at Clinical Trials.gov

Trial results on Cidfusituzumab

Clinical Trials on Cidfusituzumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cidfusituzumab

NICE Guidance on Cidfusituzumab

NHS PRODIGY Guidance

FDA on Cidfusituzumab

CDC on Cidfusituzumab

Books

Books on Cidfusituzumab

News

Cidfusituzumab in the news

Be alerted to news on Cidfusituzumab

News trends on Cidfusituzumab

Commentary

Blogs on Cidfusituzumab

Definitions

Definitions of Cidfusituzumab

Patient Resources / Community

Patient resources on Cidfusituzumab

Discussion groups on Cidfusituzumab

Patient Handouts on Cidfusituzumab

Directions to Hospitals Treating Cidfusituzumab

Risk calculators and risk factors for Cidfusituzumab

Healthcare Provider Resources

Symptoms of Cidfusituzumab

Causes & Risk Factors for Cidfusituzumab

Diagnostic studies for Cidfusituzumab

Treatment of Cidfusituzumab

Continuing Medical Education (CME)

CME Programs on Cidfusituzumab

International

Cidfusituzumab en Espanol

Cidfusituzumab en Francais

Business

Cidfusituzumab in the Marketplace

Patents on Cidfusituzumab

Experimental / Informatics

List of terms related to Cidfusituzumab


Overview

Cidfusituzumab is a humanized monoclonal antibody which is used to treat cancers of the epithelial origin. It binds to interleukin-2.



Linked-in.jpg